Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

Please share Science & Enterprise

Biotech, Regeneron in $2B Cancer Antibody Deal

Cancer magnified

A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies. . . . → Read More: Biotech, Regeneron in $2B Cancer Antibody Deal

Company to Boost Orphan Drugs in Europe

Europe at night from space

A start-up enterprise seeks to make drugs for treating rare diseases more readily available to physicians and patients in Europe. . . . → Read More: Company to Boost Orphan Drugs in Europe

Covid-19 Vaccine Patch Clinical Trial Begins

Vaccine patch

Developers of a patch with tiny needles instead of a syringe to deliver vaccines say a clinical trial testing a Covid-19 patch is now underway in Australia. . . . → Read More: Covid-19 Vaccine Patch Clinical Trial Begins

Trial in Progress of Antibody Blocking Covid-19 in Immunocompromised

Global Covid-19

A clinical trial is underway testing a synthetic antibody designed to prevent SARS-CoV-2 viral infections in people with compromised immune systems. . . . → Read More: Trial in Progress of Antibody Blocking Covid-19 in Immunocompromised

Drug Licensed for Precision Autism Spectrum Therapies

Brain activity graphic

A company making precision therapies for neurological disorders is acquiring rights to a compound first designed as a treatment for cancer, inflammation, and oxidative stress. . . . → Read More: Drug Licensed for Precision Autism Spectrum Therapies

Patent Issued for Crispr-Edited Viruses in Microbiome

Crispr-Cas9

A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments. . . . → Read More: Patent Issued for Crispr-Edited Viruses in Microbiome

Start-Up Licenses Gene-Edited Drug Discovery Tech.

African clawed frog

A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases. . . . → Read More: Start-Up Licenses Gene-Edited Drug Discovery Tech.

Venture to Build Cell, Gene Therapy Businesses

Gene therapy graphic

A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs. . . . → Read More: Venture to Build Cell, Gene Therapy Businesses

Cannabinoid Synthesis Process Licensed to Spin-Off Company

DNA illustration

A genetic technology for synthesizing cannabinoid compounds without cannabis cells was licensed to a company spun-off from the lab that developed the process. . . . → Read More: Cannabinoid Synthesis Process Licensed to Spin-Off Company

Univ. Labs Ink Licensing Deals for Covid-19 Tests

Home testing station

Two companies agreed to license technologies from academic labs in the U.S. and U.K. for developing faster and more sensitive at-home tests for Covid-19 infections. . . . → Read More: Univ. Labs Ink Licensing Deals for Covid-19 Tests